NBY isn't slowing down this morning.


(NBY) Continues To Heat Up, Posts New High Of Day (Up Approximately 38%)

December 30th

Greetings Readers,

NBY isn't slowing down this morning.

Posting a new day high of $1.93, NBY is bringing the heat first thing and is up approximately 38%.

Could this be the start of something spectacular?

Get NBY pulled up before it's too late.


Let's get straight to it this AM.

I've uncovered a new, tiny float, NYSE American profile requiring immediate attention.

Drop everything and get *NovaBay Pharmaceuticals, Inc. (NBY)* on your radar.

Here's why...

NBY has a tiny, tiny float.

Yahoo Finance reports that NBY has a float in the ballpark of 1.58Mn shares.

What does this mean? It means that volatility could surround NBY on a daily basis.

With such few shares available for trading, NBY is used to volatile surges intraday and short term.

Just take a look at NBY's day yesterday. Opening at $1.29, it rocketed to a high of $1.60 on the day.

That $.31 move resulted in NBY moving 24% intraday.

The move came on the heels of no new news. Nothing really spectacular standing out.

Need more proof? Take a look at NBY's 1-year chart. In it, you'll find several explosive short term and intraday surges.

Additionally, NBY released positive Q3 financial news including seeing 69% revenue growth.

NovaBay CEO, Justin Hall, shared:

"Revenues grew an impressive 69% as we benefited from the DERMAdoctor acquisition and our expanded product portfolio. Highlights of the quarter include the most DERMAdoctor product sales since the acquisition and continued year-over-year growth in online Avenova Spray unit sales. Avenova companion products and our branded wound care products also made solid contributions to revenue during the quarter."

Most recently, NBY provided this important update:

NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China

Douyin, China’s TikTok counterpart, drives 26% increase in DERMAdoctor sales and 258% more visitors to its online stores during Double 11 event

EMERYVILLE, Calif., November 29, 2022--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the expansion of its lifestyle promotional video campaigns on TikTok and its Chinese counterpart Douyin to reach new customers for its Avenova® and DERMAdoctor® brand products.

"We are expanding our e-commerce presence for DERMAdoctor products in China, which is the world’s largest e-commerce market, accounting for more than 50% of global e-commerce transactions," said Justin Hall, CEO of NovaBay Pharmaceuticals. "UNQ Group, our new marketing partner in China, is running influencer videos through its Fancy subsidiary on Douyin, while also developing e-commerce strategies and offering integrated solutions to promote our DERMAdoctor products in this exceptionally large market for skincare products. Douyin is the leading short-video app in China and our new influencer videos provide an opportunity to efficiently reach customers among its 550 million active monthly users."

Read the full article here.


NovaBay Pharmaceuticals, Inc. (NBY) Company Breakdown


NovaBay Pharmaceuticals, Inc. develops and sells problem-solving, accessible solutions for improved well-being. Our leading product, Avenova® Antimicrobial Lid and Lash Solution, is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with our proprietary, stable and pure form of hypochlorous acid and is cleared by the U.S. Food and Drug Administration for sale in the United States. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Other eye care products offered under the Avenova eye care brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress, and the i-Chek.


DERMAdoctor offers over 30 dermatologist-developed products targeting common skin concerns, ranging from aging and blemishes to dry skin, perspiration and keratosis pilaris. DERMAdoctor branded products are marketed and sold through the DERMAdoctor website, well-known traditional and digital beauty retailers, and a network of international distributors.


We also manufacture and sell our proprietary form of hypochlorous acid for the wound care market. NeutroPhase and PhaseOne are used for the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. NeutroPhase and PhaseOne are gentle, non-irritating, and non-sensitizing to skin and new tissue. PhaseOne is distributed through commercial partners in the United States for professional use only, and NeutroPhase is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.

More Info - Company Presentation


Drop everything and get NBY pulled up immediately. If there are any updates today, I'll have them out quickly. When time permits, do this:


Get NBY on your radar now.


Kai Parker


(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

StockWireNews (stockwirenews . com) is owned by SWN Media LLC, a limited liability company. Disclosure: I am not a lice.nsed finan.cial adviser. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading StockWireNews email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at www.stockwirenews.net/disclosure An owner of SWN Media LLC owns and operates smallcapfirm . com (“SCF”), owns and operates fierceinvestor . com (“FI”), and owns and operates stockstreetwire . com ("SSW"). From time to time, StockWireNews, SCF, FI, and/or SSW will publicly disseminate information about a company via website, email, SMS and other points of media. Ownership of "FI" and "SSW" has now moved to a single individual. We have not been compensated for today's profile on (NBY). We own zero shares of (NBY). We anticipate to potentially do marketing for (NBY) at a future date. If that occurs, we will disclose compensation accordingly.